We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThrogmorton Trust Regulatory News (THRG)

Share Price Information for Throgmorton Trust (THRG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 592.00
Bid: 589.00
Ask: 591.00
Change: 6.00 (1.02%)
Spread: 2.00 (0.34%)
Open: 588.00
High: 592.00
Low: 586.00
Prev. Close: 586.00
THRG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Circular and Notice of GM

9 Sep 2021 07:00

BlackRock Throgmorton Trust Plc - Publication of Circular and Notice of GM

BlackRock Throgmorton Trust Plc - Publication of Circular and Notice of GM

PR Newswire

London, September 8

BlackRock Throgmorton Trust PLC (the “Company”)

LEI: 5493003B7ETS1JEDPF59

Publication of Circular and Notice of General Meeting

The Board has today published a circular (the "Circular") convening a general meeting to be held at 11.00 a.m. on Monday, 4 October 2021 (the "General Meeting").

At the Company's annual general meeting on 24 March 2021 (the "2021 AGM"), the Directors were given authority, inter alia, to allot new shares and sell shares from treasury on a non-pre-emptive basis up to an aggregate nominal amount of £447,852.00, representing 8,957,040 Ordinary Shares, equivalent to 10% of the Company’s issued share capital excluding Tresaruy shares at the time (the "Existing Authority").

Since the 2021 AGM, the Company has issued new Ordinary Shares on a regular basis to meet market demand for the Company's shares and to manage the premium to NAV at which the Ordinary Shares continue to trade. At the current rate of issuance, it is likely that the Existing Authority will be exhausted well before the Company's 2022 AGM, expected to be held in March 2022.

The Directors consider that it is in Shareholders' interests that the Company continues to have the flexibility to issue Ordinary Shares in order to provide liquidity and to ensure that it can manage the premium to NAV at which its Ordinary Shares may trade, in line with its discount/premium control policy.

Accordingly, in order to retain this flexibility, the Board is now seeking to replace the Existing Authority with renewed Shareholder authorities (the "New Authority") to issue new Ordinary Shares of the Company on a non-pre-emptive basis, such authority to expire at the conclusion of the next annual general meeting to be held in 2022 (the "Proposals").

The New Authority is being sought by way of four separate resolutions in order to give Shareholders the opportunity to vote separately on: (i) an authority to allot up to 10 per cent. of the Company's issued share capital at the latest practicable date prior to the publication of the Circular on a non-pre-emptive basis; and (ii) an additional authority to allot up to a further 10 per cent. of the Company's issued share capital at the latest practicable date prior to the publication of the Circular on a non-pre-emptive basis.

As Ordinary Shares will only be issued under the Proposals at a premium to the prevailing NAV at the time of issue intended to exceed the expected costs and expenses of the relevant issue, any use of the New Authority is expected to be accretive to the NAV per Ordinary Share.

The Directors are accordingly convening a General Meeting to be held at the offices of BlackRock Investment Management (UK) Limited at 12 Throgmorton Avenue, London EC2N 2DL on Monday 4 October 2021 at 11:00 a.m. at which the relevant Resolutions will be put to Shareholders.

Further details of, and reasons for, the Proposals are set out in the Circular.

The General Meeting

The Proposals are conditional on the approval by Shareholders of the Resolutions to be proposed at the General Meeting which has been convened for 11:00 a.m. on Monday 4 October 2021.

In accordance with the Articles, all Shareholders present in person or by proxy shall upon a show of hands have one vote and upon a poll shall have one vote in respect of each Ordinary Share held. In order to ensure that a quorum is present at the General Meeting, it is necessary for two Shareholders entitled to vote to be present, whether in person or by proxy (or, if a corporation, by a representative).

All Shareholders are entitled to attend and vote at the General Meeting. However, as explained below, Shareholders are asked to submit a proxy vote in advance of the General Meeting.

The formal notice convening the General Meeting can be found in the Circular.

Action to be taken in respect of the General Meeting

In light of the ongoing COVID-19 pandemic, Shareholders are strongly encouraged to submit a proxy vote in advance of the General Meeting, either by completing the hard copy Form of Proxy or online by following the instructions set out in the Circular. Although UK Government restrictions on public gatherings are no longer in force in connection with COVID-19, it is possible that such restrictions could be reimposed prior to the date of the General Meeting. Such restrictions could mean that the General Meeting is required to be held as a closed meeting with physical attendance limited to only a small number of attendees comprising the required quorum for the meeting and those persons whose attendance is necessary for the conduct of the meeting, and that any other persons will be refused entry. Shareholders are also requested not to attend the General Meeting if they are required to self-isolate pursuant to UK Government guidance. Accordingly, all Shareholders are recommended to vote by proxy in advance of the General Meeting and to appoint the Chairman of the meeting as their proxy. This will ensure that Shareholders’ votes will be counted even if they (or any appointed proxy) are not able to attend, including if any such person is required to self-isolate pursuant to UK Government guidance or if restrictions on attendance at public meetings have been reintroduced. All votes will be taken by poll so that all proxy votes are counted.

The Company may impose entry restrictions on persons wishing to attend the General Meeting (including, if required, refusing entry) in order to secure the orderly conduct of the General Meeting and the safety of the attendees. Such restrictions may include, but are not limited to, the requirement to maintain social distancing, the wearing of masks and temperature checks.

Shareholders will find enclosed with the Circular a personalised Form of Proxy for use at the General Meeting. Shareholders are asked to complete and return the Form of Proxy, in accordance with the instructions printed thereon, to the Company's Registrar, Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol BS99 6ZY so as to be received as soon as possible and, in any event, by no later than 11:00 a.m. on Thursday 30 September 2021.

The return of a Form of Proxy will not prevent Shareholders from attending the General Meeting and voting in person should they so wish, subject to any restrictions on attendance due to COVID-19. However, Shareholders are requested to complete and return a Form of Proxy whether or not they wish to attend the General Meeting.

 Expected timetable

Latest time and date for receipt of Forms of Proxy or transmission of CREST Proxy Instructions for the General Meeting 11.00 a.m. on 30 September 2021
General Meeting11.00 a.m. on 4 October 2021
All references to timings in this announcement are to London time unless otherwise stated.

 Terms used and not defined in this announcement shall have the meanings given to them in the Circular.

A copy of the Circular has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

The Circular will also shortly be available on the Company's website at: www.blackrock.com/uk/thrg/gm-circular.

Contact details for queries:

BlackRock Investment Management (UK) LimitedSimon WhiteKevin MaygerTel: 020 7743 3000

Stifel Nicolaus Europe LimitedMark BloomfieldEdward Gibson-Watt

Tel: 020 7710 7600 

Date   Source Headline
2nd May 20245:50 pmPRNTransaction in Own Shares
2nd May 20245:26 pmPRNDisclosure of Portfolio Holdings
2nd May 202412:06 pmPRNNet Asset Value(s)
2nd May 20247:00 amPRNTotal Voting Rights
1st May 20246:33 pmPRNTransaction in Own Shares
1st May 202412:05 pmPRNNet Asset Value(s)
1st May 20247:00 amPRNTotal Voting Rights
30th Apr 20245:44 pmPRNTransaction in Own Shares
30th Apr 202412:06 pmPRNNet Asset Value(s)
30th Apr 20247:00 amPRNTotal Voting Rights
29th Apr 20245:51 pmPRNTransaction in Own Shares
29th Apr 20244:59 pmPRNPortfolio Update
29th Apr 202412:24 pmPRNNet Asset Value(s)
29th Apr 20247:00 amPRNTotal Voting Rights
26th Apr 20245:36 pmPRNTransaction in Own Shares
26th Apr 202411:42 amPRNNet Asset Value(s)
26th Apr 20247:00 amPRNTotal Voting Rights
25th Apr 20246:00 pmPRNTransaction in Own Shares
25th Apr 20245:45 pmPRNDirector/PDMR Shareholding
25th Apr 202412:11 pmPRNNet Asset Value(s)
25th Apr 20247:00 amPRNTotal Voting Rights
24th Apr 20245:54 pmPRNTransaction in Own Shares
24th Apr 202412:11 pmPRNNet Asset Value(s)
24th Apr 20247:00 amPRNTotal Voting Rights
23rd Apr 20245:41 pmPRNTransaction in Own Shares
23rd Apr 202412:11 pmPRNNet Asset Value(s)
23rd Apr 20247:00 amPRNTotal Voting Rights
22nd Apr 20245:52 pmPRNTransaction in Own Shares
22nd Apr 202411:52 amPRNNet Asset Value(s)
22nd Apr 20247:00 amPRNTotal Voting Rights
19th Apr 20246:00 pmPRNTransaction in Own Shares
19th Apr 202412:05 pmPRNNet Asset Value(s)
19th Apr 20247:00 amPRNTotal Voting Rights
18th Apr 20246:36 pmPRNTransaction in Own Shares
18th Apr 202412:14 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 20245:58 pmPRNTransaction in Own Shares
17th Apr 202412:12 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:45 pmPRNTransaction in Own Shares
16th Apr 202412:00 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:54 pmPRNTransaction in Own Shares
15th Apr 202411:34 amPRNNet Asset Value(s)
15th Apr 20247:00 amPRNTotal Voting Rights
12th Apr 20246:50 pmPRNTransaction in Own Shares
12th Apr 202412:32 pmPRNDirector/PDMR Shareholding
12th Apr 202412:12 pmPRNNet Asset Value(s)
12th Apr 20247:00 amPRNTotal Voting Rights
11th Apr 20245:55 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.